Key gp120 Glycans Pose Roadblocks to the Rapid Development of VRC01-Class Antibodies in an HIV-1-Infected Chinese Donor
Authors:
Abstract
No abstract availableKeywords
Funding Information
- US Department of Energy, Basic Energy Sciences, Office of Science (DE-AC02-06CH11357)
- National Major projects for Infectious Diseases Control and Prevention (2012ZX10001008)
- International AIDS Vaccine Initiative Neutralizing Antibody Center
- CAVD
- Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (UM1 AI100663)
- HIV Vaccine Research and Design (HIVRAD) program (P01 AI110657)
- Joint Center of Structural Genomics
- NIH NIGMS, Protein Structure Initiative (U54 GM094586)
- SKLID Development (2012SKLID103)
- NIH NIAID (R01 AI102766, AI084817)
- NIH NIAID development (P30AI36214)
- Center for AIDS Research at the University of California, San Diego
- NIH CIPRA (U19AI51915)
- American Foundation for AIDS Research Mathilde Krim Fellowship in Basic Biomedical Research
This publication has 40 references indexed in Scilit:
- Increasing the Potency and Breadth of an HIV Antibody by Using Structure-Based Rational DesignScience, 2011
- Polyclonal B Cell Responses to Conserved Neutralization Epitopes in a Subset of HIV-1-Infected IndividualsJournal of Virology, 2011
- Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep SequencingScience, 2011
- Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 BindingScience, 2011
- The Neutralization Breadth of HIV-1 Develops Incrementally over Four Years and Is Associated with CD4 + T Cell Decline and High Viral Load during Acute InfectionJournal of Virology, 2011
- Characteristics of the Earliest Cross-Neutralizing Antibody Response to HIV-1PLOS Pathogens, 2011
- Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01Science, 2010
- Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1Science, 2010
- A Limited Number of Antibody Specificities Mediate Broad and Potent Serum Neutralization in Selected HIV-1 Infected IndividualsPLOS Pathogens, 2010
- Rational antibody-based HIV-1 vaccine design: current approaches and future directionsCurrent Opinion in Immunology, 2010